
I noted an interesting comment posted in the comment thread of Bob Wachter's post "Putting the “A” Back in SOAP Notes: Time to Tack...
I noted an interesting comment posted in the comment thread of Bob Wachter's post "Putting the “A” Back in SOAP Notes: Time to Tack...
A striking illustration of the hazards to patients' and the public's health from health care organizational leaders using fashionabl...
As I have written in the past, beware claims of "revolutions" where healthcare or medical research are involved. As in a slide in...
Two recent interesting settlements at Massachusetts General Hospital (MGH), both involving technology. The first case involved a medication...
On the 1BoringOldMan blog, semi-anonymous blogger Mickey has been dissecting in detail the infamous Study 329 that GlaxoSmithKline used to p...
Here are a few reasonable questions I decided to elevate as a post of its own. In the face of the discovery of industry influence over comme...
Note: Also see the followup Sept. 5, 2012 post " Was EPIC successful in watering down the Meaningful Use Stage 2 Final Rule? " at ...